Opus Genetics is trading 6.2% down at $3.20 in pre-market as the stock pulls back following a sharp three-day rally from $3.05 to $3.41.
- The move appears to be a normal consolidation in a low-liquidity pre-market environment rather than a reaction to new fundamental information.
- There are no fresh company-specific headlines, earnings releases, or analyst calls tied to July 29, 2026.